Sernova Biotherapeutics (SVA.TO) Q3 2024 Earnings

16SepConfirmed
Q4 2023
Q4 2023
Q2 2024
Q3 2024
-0.03
-0.03
-0.02
-0.02

Details

Expected EPS
-0.027054857874
Actual EPS
-0.019676260272
Surprise EPS
0.01
Surprise Percent
+27.27%

Description

Sernova Biotherapeutics (SVA.TO) has reported earnings of -0.019676260272 per share for Q3 2024.

0 Comments

Share your thoughts